Methylene blue-mediated photodynamic therapy induces mitochondria-dependent apoptosis in HeLa cell

Journal of Cellular Biochemistry

Volumn 105, Issue 6, 2008, Pages 1451-1460

  Lu, Yan ^a   Jiao, Ruiqing ^a   Chen, Xiaoping ^a   Zhong, Jieying ^a   Ji, Anguo ^b   Shen, Pingping ^a  

^a NANJING UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Apoptosis; HeLa cell; Methylene blue; Mitochondria proteomics; Photodynamic therapy

Indexed keywords

CASPASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME C; ELONGATION FACTOR TU; METHYLENE BLUE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CASPASE 3; CELL DEATH; HELA CELLS; HUMANS; METHYLENE BLUE; MITOCHONDRIA; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTEOMICS;

EID: 57349143415     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21965     Document Type: Article

References (44)

1. Almeida RD, Manadas BJ, Carvalho AP, Duarte CB. 2004. Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 1704:59-86.
2. Ball DJ, Luo Y, Kessel D, Griffiths J, Brown SB, Vernon DI. 1998. The induction of apoptosis by a positively charged methylene blue derivative. J Photochem Photobiol B 42:159-163.
3. Bellin JS, Mohos SC, Oster G. 1961. Dye-sensitized photoinactivation of tumor cells in vitro. Cancer Res 21:1365-1371.
4. Buytaert E, Dewaele M, Agostinis P. 2007. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776:86-107.
5. Carmen G, Guido K. 2004. Life's smile, death's grin: Vital functions of apoptosis-executing proteins. Curr Opin Cell Biol 16:639-646.
6. Chang TS, Cho CS, Park S, Yu S, Kang SW, Rhee SG. 2004. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 279:41975-41984.
7. Chiang CW, Kanies C, Kim KW, Fang WB, Parkhurst C, Xie MH, Henry T, Yang E. 2003. Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol Cell Biol 23:6350-6362.
8. Cordoba F, Braathen LR, Weissenberger J, Vallan C, Kato M, Nakashima I, Weis J, von Felbert V. 2005. 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma. Exp Dermatol 14:429-437.
9. Cory S, Adams JM. 2002. The Bcl2 family: Regulators of the cellular life-ordeath switch. Nat Rev Cancer 2:647-656.
10. Dolmans DE, Fukumura D, Jain RK. 2003. Photodynamic therapy for cancer. Nat Rev Cancer 3:380-387.
11. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. 1998. Photodynamic therapy. J Natl Cancer Inst 90:889-905.
12. Downward J. 1999. How BAD phosphorylation is good for survival. Nat Cell Biol 1:33-35.
13. Felts SJ, Owen BAL, Nguyen P, Trepel J, Donner DB, Toft DO. 2000. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275:3305-3312.
14. Furre IE, Shahzidi S, Luksiene Z, Møller MT, Borgen E, Morgan J, Tkacz-Stachowska K, Nesland JM, Peng Q. 2005. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res 65:11051-11060.
15. Gabrielli D, Belisle E, Severino D, Kowaltowski AJ, Baptista MS. 2004. Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions. Photochem Photobiol 79:227-232.
16. Gill WB, Taja A, Chadbourne DM, Roma M, Vermeulen CW. 1987. Inactivation of bladder tumor cells and enzymes by methylene blue plus light. J Urol 138:1318-1320.
17. Henderson BW, Doughterty TJ. 1992. How does photodynamic therapy work? Photochem Photobiol 55:145-157.
18. Hopper C. 2000. Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol 1:212-219.
19. Horbinski C, Chu CT. 2005. Kinase signaling cascades in the mitochondrion: A matter of life or death. Free Radic Biol Med 38:2-11.
20. Hua G, Zhang Q, Fan Z. 2007. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem 282:20553-20560.
21. Jeppesen MG, Navratil T, Spremulli LL, Nyborg J. 2005. Crystal structure of the bovine mitochondrial elongation factor Tu-Ts complex. J Biol Chem 280:5071-5081.
22. Kirszberg C, Rumjanek VM, Capella MAM. 2005. Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: A possible use in chemotherapy. Cancer Chemother Pharmacol 55:659-665.
23. Klumpp S, Krieglstein J. 2002. Serine/threonine protein phosphatases in apoptosis. Curr Opin Pharmacol 2:458-462.
24. Koh PO. 2007. Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation. Neurosci Lett 412:68-72.
25. Manyak MJ, Russo A, Smith PD, Glatstein E. 1998. Photodynamic therapy. J Clin Oncol 6:380-391.
26. Noodt BB, Rodal GH, Wainwright M, Peng Q, Horobin R, Nesland JM, BERG K. 1998. Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer 75:941. 948.
27. Orth K, Beck G, Genze F, Ruck A. 2000. Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J Photochem Photobiol B 57:186-192.
28. Reynolds T. 1997. Photodynamic therapy expands its horizons. J Natl Cancer Inst 89:112-114.
29. Roberts DL, Frerman FE, Kim JJP. 1996. Three-dimensional structure of human electron transfer flavoprotein to 2.1-Å resolution. Proc Natl Acad Sci 93:14355-14360.
30. Rodrigues T, de Franca LP, Kawai C, de Faria PA, Mugnol KCU, Braga FM, Tersariol ILS, Smaili SS, Nantes IL. 2007. Protective role of mitochondrial unsaturated lipids on the preservation of the apoptotic ability of cytochrome c exposed to singlet oxygen. J Biol Chem 282:25577-25587.
31. Schmidt S, Schultes B, Wagner U, Oehr P, Decleer W, Lubaschowski H, Biersack HJ, Krebs1 D. 1991. Photodynamic laser therapy of carcinomas-Effects of five different photosensitizers in the colony-forming assay. Arch Gynecol Obstet 249:9-14.
32. Tardivo JP, Giglio AD, Oliveira CSD, Gabrielli SD, Junqueira HC, Tada DB, Severinob D, Turchiellob RdF, Mauricio S, Baptista PhD. 2005. Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagn Photodyn Therapy 2:175-191.
33. Tuite EM, Kelly JM. 1993. Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J Photochem Photobiol B 21:103-124.
34. Vakkila J, Lotze MT. 2004. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4:641. 648.
35. Valenti G, Procino G, Liebenhoff U, Frigeri A, Benedetti PA, Ahnert-Hilger G, Nürnberg B, Svelto M, Rosenthal W. 1998. A heterotrimeric G protein of the Gi family is required for cAMP-triggered trafficking of aquaporin 2 in kidney epithelial cells. J Biol Chem 273:22627-22634.
36. Vantieghem A, Xu Y, Assefa Z, Piette J, Vandenheede JR, Merlevede W, de Witte PAM, Agostinis P. 2002. Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis. J Biol Chem 277:37718-377313.
37. Wang X, Phelan SA, Forsman-Semb K, Taylor EF, Petros C, Brown A, Lerner CP, Paigen B. 2003. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem 278:25179-25190.
38. Waterhouse NJ, Goldstein JC, Ahsen OV, Schuler M, Newmeyer DD, Green DR. 2001. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 153:319-328.
39. Won J, Kim DY, La M, Kim D, Meadows GG, Joe CO. 2003. Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis. J Biol Chem 278:19347-19351.
40. Xie X, Li S, Liu S, Lu Y, Shen P, Ji J. 2008. Proteomic analysis of mouse islets after multiple low-dose streptozotocin injection. Biochim Biophys Acta 784:276-284.
41. Yao J, Zhang GJ. 1996. Loss of lysosomal integrity caused by the decrease of proton translocation in methylene blue-mediated photosensitization. Biochim Biophys Acta 1284:35-40.
42. Yu L, Packman LC, Weldon M, Hamlett J, Rhodes JM. D 2004. Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalin. J Biol Chem 279:41377-41383.
43. Zhang LZ, Tang GQ. 2005. The binding properties of photosensitizer methylene blue to herring sperm DNA: A spectroscopic study. J Photochem Photobiol B 74:119-125.
44. Zhou B, Yang W, Ji JG, Ru BG. 2004. Differential display proteome analysis of PC-12 cells transiently transfected with metallothionein-3 gene. J Proteome Res 3:126-131.